HHT patients with Drosha mutations exhibit a range of vascular defects stemming from abnormal vascular endothelial cell structure and functions, including epistaxis, telangiectasias, and arteriovenous malformations (AVMs).16 Here, DROSHA is linked to telangiectasis.